NEW YORK, Nov. 6, 2008 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight biowarfare pathogens, today announced that the Company's CEO, Dr. Eric A. Rose, will be presenting at the Rodman and Renshaw Annual Global Investment Conference, on Tuesday, November 11, 2008 at 9:30 a.m. ET at The New York Palace Hotel in New York City.
Dr. Rose will give a 20-minute presentation regarding SIGA Technologies' market positioning, financial performance, and strategic direction, followed by a 5-minute question and answer session. The conference is hosting a live webcast of Dr. Rose's presentation. To access the live webcast off the event, visit the Investor Relations section of the Company's website, www.siga.com, under 'Events & Presentations.' A replay of the event will be available for 90 days following the presentation.
About SIGA Technologies, Inc.
SIGA Technologies is applying viral and bacterial genomics and sophisticated computational modeling in the design and development of novel products for the prevention and treatment of serious infectious diseases, with an emphasis on products for biological warfare defense. SIGA believes that it is a leader in the development of pharmaceutical agents to fight potential bio-warfare pathogens. SIGA has antiviral programs targeting smallpox and other Category A pathogens, including arenaviruses (Lassa fever, Junin, Machupo, Guanarito, Sabia, and lymphocytic choriomeningitis), dengue virus, and the filoviruses (Ebola and Marburg). For more information about SIGA, please visit SIGA's Web site at http://www.siga.com/.
The SIGA Technologies, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=4504